SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)
ALXN 182.500.0%Jul 28 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (262)2/21/2003 10:34:47 AM
From: rkrw  Read Replies (1) of 824
 
Last update I heard was they were over 2/3rd through enrollment of 3,000 patient primo-cabg phase III. This was from Bell at the JP Morgan presentation in early January.

mapdigital.com

I was under the impression they were ahead of schedule. According to Bell they expect complete enrollment this half of the year. I'd think this could come very soon.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext